Ex vivo glioblastoma migration phenotypes define clinical recurrence and tumor heterogeneity
Glioblastoma’s pronounced migratory capacity underlies its diffuse invasion, presenting a formidable barrier to successful treatment. Ex vivo characterization of glioblastoma cells isolated from freshly resected clinical samples under physiologically relevant conditions revealed two distinct migratory phenotypes, Fast-...